X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
hematology (21) 21
transplantation (21) 21
female (18) 18
humans (18) 18
male (18) 18
stem cells (16) 16
adult (15) 15
middle aged (15) 15
immunology (14) 14
hematology, oncology and palliative medicine (12) 12
aged (9) 9
article (9) 9
busulfan (9) 9
acute myeloid-leukemia (8) 8
adolescent (8) 8
hematopoietic stem cells (8) 8
risk (8) 8
survival analysis (8) 8
treatment outcome (8) 8
acute myelogenous leukemia (7) 7
analysis (7) 7
bone-marrow-transplantation (7) 7
care and treatment (7) 7
leukemia, myeloid, acute - mortality (7) 7
leukemia, myeloid, acute - therapy (7) 7
prognosis (7) 7
recurrence (7) 7
fludarabine (6) 6
hematopoietic stem cell transplantation - methods (6) 6
mortality (6) 6
pediatrics (6) 6
relapse (6) 6
retrospective studies (6) 6
stem-cell transplantation (6) 6
survival rate (6) 6
versus-host-disease (6) 6
aml (5) 5
diseases (5) 5
infants (5) 5
leukemia (5) 5
oncology (5) 5
patient outcomes (5) 5
remission induction (5) 5
transplantation, homologous (5) 5
vidarabine - analogs & derivatives (5) 5
young adult (5) 5
age factors (4) 4
allogeneic stem cell transplantation (4) 4
cancer (4) 4
child (4) 4
children (4) 4
cyclophosphamide (4) 4
daily intravenous busulfan (4) 4
dosage and administration (4) 4
graft vs host disease - etiology (4) 4
hematopoietic stem cell transplantation (4) 4
myelodysplastic syndrome (4) 4
myelodysplastic syndromes - mortality (4) 4
myelodysplastic syndromes - therapy (4) 4
outcomes (4) 4
stem cell transplantation (4) 4
1st complete remission (3) 3
abridged index medicus (3) 3
acute lymphoblastic-leukemia (3) 3
busulfan - administration & dosage (3) 3
chemotherapy (3) 3
cohort studies (3) 3
conditioning regimen (3) 3
disease-free survival (3) 3
graft vs host disease - mortality (3) 3
graft-versus-host reaction (3) 3
hematopoietic stem cell transplantation - adverse effects (3) 3
hematopoietic stem cell transplantation - mortality (3) 3
infant (3) 3
internal tandem duplication (3) 3
leukemia, myeloid, acute - genetics (3) 3
leukemia, myeloid, acute - pathology (3) 3
medical research (3) 3
medicine, experimental (3) 3
mutation (3) 3
plus cyclophosphamide (3) 3
t cells (3) 3
transplantation conditioning - methods (3) 3
transplants & implants (3) 3
usage (3) 3
vidarabine - therapeutic use (3) 3
abstracts (2) 2
acute disease (2) 2
acute myeloblastic-leukemia (2) 2
acute myeloid leukemia (2) 2
adults (2) 2
age (2) 2
aged patients (2) 2
allogeneic transplantation (2) 2
allografts (2) 2
association (2) 2
babies (2) 2
birth-weight infants (2) 2
blood (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 05/2015, Volume 125, Issue 19, pp. 2885 - 2892
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 6, pp. 898 - 903
Abstract This study was conducted to retrospectively compare the clinical outcomes after transplantation of T cell–depleted (TCD) and unmodified allografts in... 
Hematology, Oncology and Palliative Medicine | AML | Stem cell transplantation | Transplant outcomes | T cell depletion | GVHD | CHRONIC MYELOGENOUS LEUKEMIA | POSTREMISSION THERAPY | CLINICAL OUTCOMES | FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | DAILY INTRAVENOUS BUSULFAN | DONOR TRANSPLANTATION | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Graft vs Host Disease - therapy | Recurrence | Thiotepa - administration & dosage | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Lymphocyte Depletion | Antilymphocyte Serum - administration & dosage | Busulfan - administration & dosage | Graft vs Host Disease - immunology | Transplantation, Homologous | Graft vs Host Disease - mortality | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Vidarabine - analogs & derivatives | Remission Induction | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Melphalan - administration & dosage | Survival Analysis | T-Lymphocytes - immunology | Aged | Vidarabine - administration & dosage | Medical colleges | Cyclophosphamide | Histocompatibility antigens | Tacrolimus | HLA histocompatibility antigens | Homografts | Stem cells | Lectins | Methotrexate | T cells | Index Medicus
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1948 - 1954
Abstract Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloid leukemia (AML) and... 
Hematology, Oncology and Palliative Medicine | Relapse | Chimerism | Acute myeloid leukemia | Myelodysplastic syndrome | IMMUNOLOGY | VERSUS-HOST-DISEASE | FLUDARABINE | CONDITIONING REGIMEN | TRANSPLANTATION | DONOR CHIMERISM | OLDER PATIENTS | HIGH-RISK | DAILY INTRAVENOUS BUSULFAN | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | Myeloablative Agonists - therapeutic use | Recurrence | Prognosis | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Myelodysplastic Syndromes - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Busulfan - therapeutic use | Leukemia, Myeloid, Acute - pathology | Hematopoietic Stem Cell Transplantation | Graft Survival | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Transplantation Chimera | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Myelodysplastic Syndromes - mortality | Survival Analysis | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Transplantation Conditioning | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - immunology | Analysis | Stem cells | Development and progression | Transplantation | T cells | Hematopoietic stem cells | Diseases
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 1, pp. 47 - 53
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 04/2017, Volume 52, Issue 4, pp. 580 - 587
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 05/2018, Volume 24, Issue 5, pp. 1079 - 1087
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1792 - 1800
Highlights • Clofarabine is safe when used with i.v. Bu+Flu in pretransplant conditioning regimens. • Pretransplant conditioning with i.v. Bu+Clo+Flu has... 
Hematology, Oncology and Palliative Medicine | Conditioning regimen | Clofarabine | Fludarabine | Busulfan | Allogeneic stem cell transplantation | TOTAL-BODY IRRADIATION | PREPARATIVE REGIMEN | Allogeneic stem cell | DAILY IV-BUSULFAN | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | IMMUNOLOGY | PLUS CYCLOPHOSPHAMIDE | ADULT ACUTE-LEUKEMIA | HEPATIC VENOOCCLUSIVE DISEASE | transplantation | DECREASED INCIDENCE | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Humans | Middle Aged | Male | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Busulfan - administration & dosage | Leukemia, Myeloid, Acute - complications | Young Adult | Myelodysplastic Syndromes - therapy | Adult | Female | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Transplantation Conditioning - methods | Child | Graft vs Host Disease - etiology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myeloid, Acute - therapy | Graft Survival | Treatment Outcome | Adenine Nucleotides - therapeutic use | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Myelodysplastic Syndromes - complications | Remission Induction | Arabinonucleosides - therapeutic use | Leukemia, Myeloid, Acute - mortality | Adolescent | Myelodysplastic Syndromes - mortality | Survival Analysis | Care and treatment | Influenza | Cancer | Myelocytic leukemia | Mortality | Stem cells | Nonlymphoid leukemia | Transplantation | Nucleoside analogs
Journal Article